Related Topics News -

     
 Title only   |   Print 
     
《大行》中金升信達生物目標價至95.3元 CVM重磅管線接力兌現

2025-07-02T  
《大行》花旗升信達生物目標價至90元 進入新階段

2025-07-02T  
《大行》摩通料MSCI中國指數下半年具備上行潛力 「增持」通訊服務、非必需消費品、醫療及原材料板塊

2025-06-30T  
《大行》野村升信達生物目標價至89.8元 續籲買入

2025-06-30T  
《大行》野村升信達生物目標價至89.8元 維持「買入」評級

2025-06-30T  
信達生物減重藥物獲批首個長期體重控制適應症

2025-06-27T  
國家藥監局批准信達生物GLP-1減重藥上市

2025-06-27T  
《信而有證》港股3個月高位回吐 眾安、信達生物折讓配股 博反彈吼眾安購14272 / 信藥購17713

2025-06-26T  
信達生物早段跌逾4% 折讓4.9%配股淨籌42.7億

2025-06-26T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.